Literature DB >> 24142909

Synthesis and antimicrobial activity of some new heterocycles incorporating the pyrazolopyridine moiety.

Sraa Abu-Melha1.   

Abstract

2-Cyano-N-(4,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide (2) was utilized as key intermediate for the synthesis of some new coumarin 3, pyridine 4, pyrrole 5, thiazole 8, pyrido[2',3':3,4]-pyrazolo-[5,1-c]triazine 7, and aminopyrazolo 10 compounds. 2-Cyano-N-(4,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-3-yl)-3-(dimethylamino)acrylamide (11) was synthesized and allowed to react with hydroxylamine, hydrazine, and guanidine to afford regioselectively the isoxazole 13, pyrazole 15, and pyrimidine 17 derivatives, respectively. The reaction of 11 with thiourea and/or with ethyl glycinate in basic medium afforded the regioisomeric pyrimidinethione 18 and 3,5-dioxo-1,4-diazepine-6-carbonitrile 23. All the synthesized products were tested and evaluated as antimicrobial agents.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Aminopyrazole; Antimicrobial activity; Pyrazolo[3,4-b]pyridine; Pyridine; Pyrimidine

Mesh:

Substances:

Year:  2013        PMID: 24142909     DOI: 10.1002/ardp.201300195

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  Mesoporous halloysite nanotubes modified by CuFe2O4 spinel ferrite nanoparticles and study of its application as a novel and efficient heterogeneous catalyst in the synthesis of pyrazolopyridine derivatives.

Authors:  Ali Maleki; Zoleikha Hajizadeh; Peyman Salehi
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

2.  Investigation of the reactivity properties of a thiourea derivative with anticancer activity by DFT and MD simulations.

Authors:  Y Sheena Mary; Y Shyma Mary; Anna Bielenica; Stevan Armaković; Sanja J Armaković; Vivek Chandramohan; Manjunath Dammalli
Journal:  J Mol Model       Date:  2021-07-03       Impact factor: 1.810

3.  Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors.

Authors:  Chiara Greco; Rosa Catania; Dario Leonardo Balacco; Vincenzo Taresco; Francesca Musumeci; Cameron Alexander; Alan Huett; Silvia Schenone
Journal:  Molecules       Date:  2020-11-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.